Facet By The Numbers – Q1 2024
FACET BY THE NUMBERS Total ESG submissions to FDA [...]
FDA Round Up – Q1 2024
FDA ROUNDUP: FDA Urges Sponsors to Conduct Third Party [...]
Did You Know – Q1 2024
DID YOU KNOW? Facet’s strategic and tactical regulatory affairs, [...]
Spotlight On Rare Disease Development – Q1 2024
FACET’S REGULATORY INNOVATION HUB HIGHLIGHTS 2 NEW CBER APPROVED [...]
Go Team! – Q1 2024
We're so proud of our team members' achievements! DANA [...]
Industry Focus – Q1 2024
Industry Focus Chinese Biotech In the Spotlight Over the [...]
Spotlight On – Q1 2024
RECENT FACET SUCCESSES - JUST A FEW HIGHLIGHTS FACET [...]
Facet Life Sciences Quarterly Update Q1 – 2024
From The Corner Office Q1 2024 Ken [...]
Facet Life Sciences Recognized in Top 10 Regulatory Services Companies for 2024
Facet Life Sciences, a leading provider of regulatory strategy [...]
New Services: Strategic Commercialization Support
In February, Facet will be launching a Strategic Commercialization [...]
gET sOCIAL